首页> 外文期刊>American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons >A comparison of long-term graft survival rates between the first and second donor kidney transplanted--the effect of a longer cold ischaemic time for the second kidney.
【24h】

A comparison of long-term graft survival rates between the first and second donor kidney transplanted--the effect of a longer cold ischaemic time for the second kidney.

机译:比较第一个和第二个供体肾脏移植后的长期移植存活率-第二个肾脏更长的冷缺血时间的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

Prolonged cold ischaemic time (CIT) is associated with delayed initial graft function and may also have a negative impact on long-term graft outcome. We carried out a study comparing the long-term graft survival rates between those recipients who received the first of a pair of donor kidneys versus the recipient of the second graft. Adult kidney transplant recipients who received one of a pair of donor kidneys at our institution between 1989-1995 were included. All recipients received a cyclosporin based immunosupression regimen. Graft survival rates were compared between the 2 groups at 1-, 3-, 5- and 10-year intervals. A total of 520 renal transplant grafts were included in this study. Mean donor age was 35.4 years. Groups were similar for recipient age, gender, number of HLA mismatches, transplant number for that patient and percentage PRA. CIT was the only variable that was significantly different between the two groups; mean of 19.93 h in the first group compared to 25.65 h in the second group. Graft survival rates for the first kidney were significantly better than the second kidney-graft survival at 1 year 88.5% versus 84.7%, at 3 years 81.8% versus 76.7%, at 5 years 72.2% versus 64.9% and at 10 years 55.2% versus 40% (p = 0.012). Patient survival rates were similar in both groups. In our experience, the long-term graft survival rates are significantly better for the first kidney transplanted compared to the second kidney.
机译:长时间的冷缺血时间(CIT)与移植物的初始功能延迟有关,也可能对移植物的长期结局产生负面影响。我们进行了一项研究,比较了接受一对供体肾脏中的第一个供体肾脏与接受第二个移植物的接受者之间的长期移植物存活率。包括在1989-1995年间在我们机构接受一对供体肾脏之一的成年肾移植受者。所有接受者均接受基于环孢菌素的免疫抑制方案。分别以1年,3年,5年和10年的间隔比较两组的移植物存活率。本研究共包括520例肾移植。平均供体年龄为35.4岁。接受者的年龄,性别,HLA错配数,该患者的移植数和PRA百分比的分组相似。 CIT是两组之间唯一显着不同的变量。第一组平均19.93小时,而第二组平均25.65小时。第一个肾脏的移植物存活率显着优于第二个肾脏移植物的存活率,分别为88.5%对84.7%,3年81.8%对76.7%,5年72.2%对64.9%和10年55.2% 40%(p = 0.012)。两组的患者生存率相似。根据我们的经验,与第二个肾脏相比,第一个肾脏移植的长期移植物存活率要好得多。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号